22 May 2013
Keywords: regeneron, initiates, safety, tolerability, trial, phase, vegf
Article | 19 April 2004
The USA's Regeneron Pharmaceuticals has initiated a Phase I clinical trial in cancer designed to evaluate the safety and tolerability ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 April 2004
© 2013 thepharmaletter.com